Company
Thyme Care
Thyme Care provides value-based oncology management and personalized cancer care navigation through dedicated care teams and technology integration.
Thyme Care is a privately held company. Leadership tracked by CEOInsider includes Dr. Brad Diephuis (CEO).
Leadership
Current
Recent developments
AI summary of recent coverageRecent coverage has focused on Thyme Care's Series E funding round of $125 million at a valuation exceeding $2 billion, alongside the establishment of a new parent entity called Thyme Companies designed to expand the company's reach across the broader oncology ecosystem. The coverage also highlighted leadership changes, with co-founder Robin Shah transitioning to Executive Chairman and Dr. Brad Diephuis assuming the role of Chief Executive Officer. Additionally, Thyme Care has attracted attention for its value-based care partnerships, including a first-of-its-kind oncology value-based agreement with Blue Cross Massachusetts.
Summarized from the headlines in the sidebar; see each source for the full story.